CIK 0001759425
- Large accelerated filer
Mirum Pharmaceuticals, Inc.
Sign in to watch- Ticker
- MIRM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831281555
- Phone
- +1 650-667-4085
- Business address
- 989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
- 4 Option exercise PRESIDENT AND COO acquired 5,912 shares (option exercise)
- 4 Planned sale Director sold 2,000 shares at $102.09 ($204,180)
- 4 Open-market sale PRESIDENT AND COO sold 2,631 shares at $103.30 ($271,792)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 9,108 shares at $103.30 ($940,888)
- 4 Open-market sale SVP, GLOBAL CONTROLLER sold 968 shares at $103.30 ($99,998)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 1,053 shares at $96.19 ($101,290)
- 4 Open-market sale PRESIDENT AND COO sold 3,143 shares at $96.19 ($302,331)
- 4 Open-market sale SVP, GLOBAL CONTROLLER sold 842 shares at $96.19 ($80,994)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 6,831 shares at $96.19 ($657,088)
- 4 Open-market buy Director bought 131,425 shares at $68.48 ($8,999,984)
- 4 Open-market sale SVP, GLOBAL CONTROLLER sold 926 shares at $93.33 ($86,419)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 1,822 shares at $93.33 ($170,039)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 1,421 shares at $93.33 ($132,615)
- 4 Open-market sale PRESIDENT AND COO sold 2,382 shares at $93.33 ($222,301)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 7,098 shares at $93.33 ($662,422)
Page 3 of 18 · 355 filings